What’s Next for the Phase II Trial? - 102164


What’s Next for the Phase II Trial?

Description: Liza Villaruz, MD of University of Pittsburgh Medical Center discusses the next steps for the clinical trial at the 2017 ASCO Annual Meeting in Chicago, IL.

Abstract TPS9105: Phase II clinical trial of atezolizumab (A) in advanced non-small cell lung cancer (NSCLC) patients (pts) previously treated with PD1-directed therapy
Shared By : AnnualMeeting2017
Posted on : 06/15/17
Added : 7 months ago


Nothing found.

More From AnnualMeeting2017

Nothing found.